BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20883227)

  • 1. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
    Bakris GL; Iyengar M; Lukas MA; Ordronneau P; Weber MA
    J Clin Hypertens (Greenwich); 2010 Sep; 12(9):678-86. PubMed ID: 20883227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of combining extended-release carvedilol and lisinopril in hypertension: results of the COSMOS study.
    Flack JM
    J Clin Hypertens (Greenwich); 2010 Sep; 12(9):664-5. PubMed ID: 20928961
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D; Glazes R; Kargiannis S; Wernsing M; Kaczor J; Chiang YT; Yen J; Gamboa R; Fomina I
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artist® tablets (carvedilol) for hypertensive patients in Japan: results of a drug use survey.
    Mori Y; Nishikawa Y; Iizuka T; Zenimura N; Matsumoto T; Hiramatsu K; Komiya M
    Drugs R D; 2011; 11(2):171-90. PubMed ID: 21679007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled-release carvedilol in the treatment of essential hypertension.
    Weber MA; Sica DA; Tarka EA; Iyengar M; Fleck R; Bakris GL
    Am J Cardiol; 2006 Oct; 98(7A):32L-38L. PubMed ID: 17023230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension.
    Wong GW; Laugerotte A; Wright JM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007449. PubMed ID: 26306578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a once-daily formulation of carvedilol for the treatment of hypertension.
    Weber MA; Bakris GL; Tarka EA; Iyengar M; Fleck R; Sica DA
    J Clin Hypertens (Greenwich); 2006 Dec; 8(12):840-9. PubMed ID: 17170609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of carvedilol, lisinopril and their combination on vascular and cardiac health in patients with borderline blood pressure: the DETECT Study.
    Saul SM; Duprez DA; Zhong W; Grandits GA; Cohn JN
    J Hum Hypertens; 2013 Jun; 27(6):362-7. PubMed ID: 23190794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in mean and variability of heart rate and ambulatory rate-pressure product when valsartan or carvedilol is added to lisinopril.
    Izzo JL; Yedlapati SH; Faheem SM; Younus U; Osmond PJ
    J Am Soc Hypertens; 2012; 6(6):399-404. PubMed ID: 23107894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study.
    Malacco E; Santonastaso M; Varì NA; Gargiulo A; Spagnuolo V; Bertocchi F; Palatini P;
    Clin Ther; 2004 Jun; 26(6):855-65. PubMed ID: 15262456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antihypertensive efficacy of carvedilol and nebivolol in mild-to-moderate primary hypertension: a randomized trial.
    Erdoğan O; Ertem B; Altun A
    Anadolu Kardiyol Derg; 2011 Jun; 11(4):310-3. PubMed ID: 21543293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol-lisinopril combination therapy and endothelial function in obese individuals with hypertension.
    Kelly AS; Gonzalez-Campoy JM; Rudser KD; Katz H; Metzig AM; Thalin M; Bank AJ
    J Clin Hypertens (Greenwich); 2012 Feb; 14(2):85-91. PubMed ID: 22277140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nisoldipine CC and lisinopril alone or in combination for treatment of mild to moderate systemic hypertension. Canadian Nisoldipine CC Hypertension Trial Group.
    Ruddy TD; Fodor JG
    Cardiovasc Drugs Ther; 1997 Sep; 11(4):581-90. PubMed ID: 9358963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of blood pressure control in left ventricular mass regression.
    Miller AB; Reichek N; St John Sutton M; Iyengar M; Henderson LS; Tarka EA; Bakris GL
    J Am Soc Hypertens; 2010; 4(6):302-10. PubMed ID: 20980215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure effects of combined β-blocker and angiotensin-converting enzyme inhibitor therapy compared with the individual agents: a placebo-controlled study with nebivolol and lisinopril.
    Weber MA; Basile J; Stapff M; Khan B; Zhou D
    J Clin Hypertens (Greenwich); 2012 Sep; 14(9):588-92. PubMed ID: 22947356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of telmisartan with lisinopril in patients with mild-to-moderate hypertension.
    Neutel JM; Frishman WH; Oparil S; Papademitriou V; Guthrie G
    Am J Ther; 1999 May; 6(3):161-6. PubMed ID: 10423659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.